Search - tctmd.com

Displaying 121 - 140 of 489

Sort: Relevancy | Date

Presentation TCT 2022

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

Presenter: Michael Haude

September 19, 2022

Presentation TCT 2022

Coronary Sinus Reduction for the Treatment of Symptomatic Microvascular Coronary Disease: Early Clinical Results

Presenter: Shmuel Banai

September 19, 2022

Presentation TCT 2022

New Tool and Technique in Coronary Microcirculatory Assessment (caIMR)

Presenter: Yana Cheng

September 19, 2022

Presentation TCT 2022

Novel Approaches to Reduce and Reverse Bleeding in Complex PCI

Presenter: C. Michael Gibson

September 19, 2022

Presentation TCT 2022

My Roadmap for Preprocedure and Intraprocedural Antithrombotic Therapy in Complex PCI

Presenter: Jennifer Rymer

September 19, 2022

Presentation TCT 2022

Reflow Medical’s Temporary Spur DES System

Presenter: Jihad Mustapha

September 17, 2022

Presentation TCT 2022

MOTIV BRS (REVA Vascular)

Presenter: Christopher Metzger

September 17, 2022

Presentation TCT 2022

APTITUDE PLLA BRS (R3 Vascular)

Presenter: Mahmood K. Razavi

September 17, 2022

Presentation TCT 2022

Hybrid Nano-Coating DES for BTK Disease

Presenter: Terumitsu Hasebe

September 17, 2022

Presentation TCT 2022

The PRELIEVE Study of the Atrial Flow Regulator

Presenter: Roman Pfister

September 17, 2022

Presentation TCT 2022

Deep Learning AI-Based Model to Guide Personalized Use of Mechanical Support Devices in Patients Presenting With Cardiogenic Shock Undergoing PCI

Presenter: Amit Amin

September 17, 2022

Presentation TCT 2022

Mission Critical Software for STEMI Care (Stenoa)

Presenter: Marco Spaziano

September 17, 2022

Presentation TCT 2022

Interatrial Shunting With No Device Left Behind

Presenter: James E. Udelson

September 17, 2022

Presentation TCT 2022

The V-Wave Study: Different Device, Different Study Population, and Perhaps Different Results?

Presenter: Gregg W. Stone

September 17, 2022

Presentation TCT 2022

AI-Based Algorithm for Determination of Clinically Significant Coronary Disease Using a 12-Lead ECG (Heartio)

Presenter: Michael Leasure

September 17, 2022

Presentation TCT 2022

New Insights Into Interatrial Shunting From the REDUCE-LAP II Study

Presenter: Sheldon E. Litwin

September 17, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Daily News

AI Tool Can Quantify CAC—and Associated CV Risk—From PET

Yael L. Maxwell

September 14, 2022

News Daily News

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Michael O'Riordan

September 13, 2022

Advertisement

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

Coronary Sinus Reduction for the Treatment of Symptomatic Microvascular Coronary Disease: Early Clinical Results

New Tool and Technique in Coronary Microcirculatory Assessment (caIMR)

Novel Approaches to Reduce and Reverse Bleeding in Complex PCI

My Roadmap for Preprocedure and Intraprocedural Antithrombotic Therapy in Complex PCI

Reflow Medical’s Temporary Spur DES System

MOTIV BRS (REVA Vascular)

APTITUDE PLLA BRS (R3 Vascular)

Hybrid Nano-Coating DES for BTK Disease

The PRELIEVE Study of the Atrial Flow Regulator

Deep Learning AI-Based Model to Guide Personalized Use of Mechanical Support Devices in Patients Presenting With Cardiogenic Shock Undergoing PCI

Mission Critical Software for STEMI Care (Stenoa)

Interatrial Shunting With No Device Left Behind

The V-Wave Study: Different Device, Different Study Population, and Perhaps Different Results?

AI-Based Algorithm for Determination of Clinically Significant Coronary Disease Using a 12-Lead ECG (Heartio)

New Insights Into Interatrial Shunting From the REDUCE-LAP II Study

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

AI Tool Can Quantify CAC—and Associated CV Risk—From PET

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content